Abstract
Background/objectives Individuals with obesity show alterations in smell and taste abilities. Smell and taste loss are also the most prominent neurological symptoms of COVID-19, yet how chemosensory ability present in individuals with obesity with a positive COVID-19 diagnosis is unknown.
Subjects/Methods In this secondary analysis of a cross-sectional global dataset, we compared self-reported chemosensory ability in participants with a respiratory illness reporting a positive (C19+; n = 5156) or a negative (C19−; n = 659) COVID-19 laboratory test outcome, who also self-reported to be obese (C19+; n = 433, C19−; n = 86) or non-obese.
Results Compared to the C19− group, C19+ exhibited a greater decline in smell, taste, and chemesthesis during illness, though these symptoms did not differ between participants with obesity and without obesity. In 68% of participants who reported recovery from respiratory illness symptoms (n=3431 C19+ and n= 539 C19−), post-recovery chemosensory perception did not differ in C19+ and C19− diagnosis, and by self-reported obesity. Finally, we found that all chemosensory and other symptoms combined predicted the C19+ diagnosis in participants with obesity with a moderately good estimate (63% accuracy). However, in C19+ participants with obesity, we observed a greater relative prevalence of non-chemosensory symptoms, including respiratory as respiratory and GI symptoms.
Conclusions We conclude that despite a presumed lower sensitivity to chemosensory stimuli, COVID-19 respondents with obesity experience a similar self-reported chemosensory loss as those without obesity, and in both groups self-reported chemosensory symptoms are similarly predictive of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Deployment of the GCCR survey was supported by an unrestricted gift from James and Helen Zallie to support sensory science research at Penn State. Paule V. Joseph is supported by the National Institute of Alcohol Abuse and Alcoholism and the National Institute of Nursing Research. PVJ is also supported by the Office of Workforce Diversity, National Institutes of Health, and the Rockefeller University Heilbrunn Nurse Scholar Award. Maria G. Veldhuizen is supported by the 2232 International Fellowship for Outstanding Researchers Program of TUBİTAK under award number 118C299.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study was approved by the Office of Research Protections of The Pennsylvania State University (STUDY00014904).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: Deployment of the GCCR survey was supported by an unrestricted gift from James and Helen Zallie to support sensory science research at Penn State. Paule V. Joseph is supported by the National Institute of Alcohol Abuse and Alcoholism and the National Institute of Nursing Research. PVJ is also supported by the Office of Workforce Diversity, National Institutes of Health, and the Rockefeller University Heilbrunn Nurse Scholar Award. Maria G. Veldhuizen is supported by the 2232 International Fellowship for Outstanding Researchers Program of TÜBİTAK under award number 118C299.
Disclosures: Competing interests: The authors declare no competing financial interests in relation to the work described.
The last name of the first author needed correction.
Data Availability
The research compendium including data files and analysis scripts is available at data in OSF